EXACT SCIENCES CORP Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount
EXACT SCIENCES CORP had Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount of $5.59 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount · last filed 2026-02-13
- 2025-12-31: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $5.59M.
- 2025-09-30: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $5.59M.
- 2025-06-30: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $5.59M.
- 2025-03-31: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $5.10M.
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount as first filed |
|---|---|---|
| 2025-12-31 | $5.59M 10-K · filed 2026-02-13 | |
| 2025-09-30 | $5.59M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $5.59M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $5.10M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $5.10M 10-K · filed 2026-02-13 | |
| 2024-09-30 | $5.10M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $5.10M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $5.10M 10-Q · filed 2025-05-01 | |
| 2023-12-31 | $5.09M 10-K · filed 2025-02-19 | $5.10M 10-K · filed 2024-02-21 |
| 2023-09-30 | $779.00K 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $779.00K 10-Q · filed 2024-07-31 | |
| 2023-03-31 | $800.00K 10-Q · filed 2024-05-08 |